According to findings from American Cancer Society researchers, very few people who could benefit from lung cancer screening – mostly current and former smokers – are actually getting the tests. (Feb. 2, 2017) Click to view.
Featured News Stories
Preora Diagnostics Named 2016’s “Best in Cancer Diagnostics” in the Americas by Corporate LiveWire
Award follows Wall Street Journal recognition as a new technology worth watching. (Nov. 29, 2016) Click to view
New Lung Cancer Screening Data from Preora Diagnostics Published in Peer-Reviewed Biomedical Optics Express
Successful optimization study moves company forward toward commercialization of PWS Nanoctyology technology platform. (Sept. 22, 2016) Click to view.
PWS Nanocytology Platform Featured on National Podcast
In the first episode of its “Amazing Things” podcast series, the national United for Medical Research coalition featured Northwestern Professor and Preora Chairman Vadim Backman, who explains why PWS Nanocytology is a breakthrough method for detecting cancer earlier than ever. (Sept. 13, 2016) Click to view
Preora Diagnostics Presenting at AdvaMed 2016’s High-profile “Innovation Showcase”
Company also participating in RESI and Cavendish conferences in September 2016.
Click here to read the full story.
AdvaMed 2016 Innovation Showcase
PWS Nanocytology Platform Named one of “Six New Medical Technologies Worth Watching”
The Wall Street Journal (June 26, 2016) highlighted our screening tests as an emerging technology that “could have a big impact on medicine in the coming years.”
Click here to read the full story.
Wall Street Journal Article
Preora Diagnostics Chairman Vadim Backman Addresses Milken Institute Global Conference 2016
Dr. Backman joins Nobel Laureate and other medical experts for prestigious panel discussion. Click to view.
Start-Up Magazine Highlights Preora Diagnostics
The highly respected and industry-leading Start-up magazine profiled Preora Diagnostics in its September 2015 issue.
Click here to read the full story.
Start-up Profile